Standard BioTools Inc (NASDAQ:LAB) traded at $1.22 at close of the session on Tuesday, June 24 and made a downward move of -0.81% on its previous day’s price.
Looking at the stock we see that its previous close was $1.23 and the beta (5Y monthly) reads 1.505 with the day’s price range being $1.17 – $1.271. In terms of its 52-week price range, LAB has a high of $2.41 and a low of $0.92. The company’s stock has gained about 27.82% over that past 30 days.
Standard BioTools Inc has a market cap of $463.38 million and is expected to release its quarterly earnings report on 2025-May-06.
On the other hand, looking at the outlook for the LAB stock, short term indicators assign the stock an average of 50% Sell, while medium term indicators assign it an average of 50% Sell.
Based on estimates by 3 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 0 have rated the Standard BioTools Inc (LAB) stock as a Hold, while 3 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is 13.52% off its SMA20 and 10.88% from its 50-day simple moving average. The RSI (14) is pointing at 60.41 while the volatility over the past week is 8.74% and jumps to 5.97% over the past one month. The average price target for the stock over the next 12 months is $3.25, with the estimates having a low of $3.25 and a high of $3.25. These price ends are -166.39% and -166.39% off the current price level respectively, although investors could be excited at the prospect of a -166.39% if the LAB share price touches on the median price of $3.25.
Coming back to Standard BioTools Inc (NASDAQ:LAB), we note that the average 3-month trading volume was 1.58 million, while that of the preceding 10-day period stands at 3.26 million. Current shares outstanding are 379.09 million.
The insiders hold 3.66% of the company’s shares while institutions hold 72.28%. The data shows that short shares as of 2025-05-30, stood at 17.04 million at a short ratio of 10.91. This represents a 765.00 short interest in shares outstanding on 2025-05-30. Shares short fall in May from the previous month at 18.44 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -36.46% down in year-to-date price movement.
